Pharmacodynamics of the initiation of antiarrhythmic therapy with lorcainide.

@article{Winkle1984PharmacodynamicsOT,
  title={Pharmacodynamics of the initiation of antiarrhythmic therapy with lorcainide.},
  author={R. Winkle and D. Keefe and I. Rodr{\'i}guez and R. Kates},
  journal={The American journal of cardiology},
  year={1984},
  volume={53 4},
  pages={
          544-51
        }
}
  • R. Winkle, D. Keefe, +1 author R. Kates
  • Published 1984
  • Medicine
  • The American journal of cardiology
    • Lorcainide is an antiarrhythmic drug with unusual pharmacokinetics and an active metabolite, norlorcainide, which complicate oral drug loading. In order to characterize the accumulation of lorcainide and norlorcainide and to define the onset of antiarrhythmic action during lorcainide loading, 9 patients with frequent ventricular ectopic beats were studied. During lorcainide loading with 100 mg orally twice daily, frequent ambulatory electrocardiographic recordings were monitored and blood… CONTINUE READING
    View on PubMed
    doi.org
    13 Citations
    Methods Citations
    1

    Topics from this paper

    Explore Further: Topics Discussed in This Paper

    13 Citations
    Citation Type

    Citation Type

    Antiarrhythmic Effect of Lorcainide in Patients Taking Digoxin
    Intravenous and oral lorcainide: assessment of central nervous system toxicity and antiarrhythmic efficacy.
    • 3
    Clinical Pharmacokinetics of the Newer Antiarrhythmic Agents
    • 52
    Pharmacokinetic Implications of Lorcainide Therapy in Patients With Normal and Depressed Cardiac Function
    • 4
    Initial and long-term outpatient experience with lorcainide for suppression of malignant and potentially malignant ventricular arrhythmias.
    • 6
    Lorcainide. A comparative trial with quinidine gluconate in patients with previously untreated ventricular arrhythmias.
    • 7
    Comparison of intravenous lorcainide with lidocaine for acute therapy of complex ventricular arrhythmias: results of a randomized study with crossover option.
    • 10
    EFFECT OF AGE ON THE CLINICAL PHARMACOKINETICS OF ANTIARRHYTHMIC DRUGS
    Comparison in vitro of the electrophysiological effects of lorcainide and its metabolite norlorcainide.
    • E. Carmeliet
    • Biology, Medicine
    • European journal of pharmacology
    • 1987
    Pharmacology of lorcainide.
    • D. Keefe
    • Medicine
    • The American journal of cardiology
    • 1984
    • 10

    References

    SHOWING 1-10 OF 12 REFERENCES
    Pharmacokinetics of Lorcainide in Man: A New Antiarrhythmic Agent
    • 49
    Lorcainide; II. Plasma concentration‐effect relationship
    • 60
    Lorcainide disposition kinetics in arrhythmia patients
    • 26
    Lorcainide; I. Saturable presystemic elimination
    • 57
    Antiarrhythmic, electrophysiologic and hemodynamic effects of lorcainide.
    • 47
    Effect of lorcainide, a new antiarrhythmic compound, on the changes in heart rhythm induced by intravenous injection of adenosine-5'-diphosphate in rats.
    • 9
    Randomized double-blind placebo controlled crossover trial documenting oral lorcainide efficacy in suppression of symptomatic ventricular tachyarrhythmias.
    • 36
    Lorcainide -- an anti-arrhythmic agent for ventricular arrhythmias.
    • 15
    Clinical experience with lorcainide (R 15 889), a new anti-arrhythmic drug.
    • 28
    ANTIFIBRILLATORY EFFICACY OF ENCAINIDE, LORCAINIDE AND ORG 6001 COMPARED WITH LIGNOCAINE IN ISOLATED HEARTS OF RABBITS AND GUINEA‐PIGS
    • 16